Home  

Random  

Nearby  



Log in  



Settings  



Donate  



About Wikipedia  

Disclaimers  



Wikipedia





Tris





Article  

Talk  



Language  

Watch  

Edit  


(Redirected from Tris(hydroxymethyl)aminomethane)
 


Tris, or tris(hydroxymethyl)aminomethane, or known during medical use as tromethamineorTHAM, is an organic compound with the formula (HOCH2)3CNH2. It is extensively used in biochemistry and molecular biology as a component of buffer solutions[2] such as in TAE and TBE buffers, especially for solutions of nucleic acids. It contains a primary amine and thus undergoes the reactions associated with typical amines, e.g., condensations with aldehydes. Tris also complexes with metal ions in solution.[3] In medicine, tromethamine is occasionally used as a drug, given in intensive care for its properties as a buffer for the treatment of severe metabolic acidosis in specific circumstances.[4][5] Some medications are formulated as the "tromethamine salt" including Hemabate (carboprost as trometamol salt), and "ketorolac trometamol".[6] In 2023 a strain of Pseudomonas hunanensis was found to be able to degrade TRIS buffer.[7]

Tris
Chemical structure of tris
Names
Preferred IUPAC name

2-Amino-2-(hydroxymethyl)propane-1,3-diol

Other names

TRIS, Tris, Tris base, Tris buffer, Trizma, Trisamine, THAM, Tromethamine, Trometamol, Tromethane, Trisaminol, Tris(hydroxymethyl)aminomethane

Identifiers

CAS Number

  • 1185-53-1 (hydrochloride) checkY
  • 6850-28-8 (acetate salt) checkY
  • 3D model (JSmol)

    ChEBI
    ChEMBL
    ChemSpider
    DrugBank
    ECHA InfoCard 100.000.969 Edit this at Wikidata
    EC Number
    • 201-064-4

    IUPHAR/BPS

    KEGG

    PubChem CID

    RTECS number
    • TY2900000
    UNII
  • 383V75M34E (hydrochloride) checkY
  • CompTox Dashboard (EPA)

    • InChI=1S/C4H11NO3/c5-4(1-6,2-7)3-8/h6-8H,1-3,5H2 checkY

      Key: LENZDBCJOHFCAS-UHFFFAOYSA-N checkY

    • InChI=1/C4H11NO3/c5-4(1-6,2-7)3-8/h6-8H,1-3,5H2

      Key: LENZDBCJOHFCAS-UHFFFAOYAN

    • OCC(N)(CO)CO

    Properties

    Chemical formula

    C4H11NO3
    Molar mass 121.136 g·mol−1
    Appearance White crystalline powder
    Density 1.328g/cm3
    Melting point >175-176 °C (448-449 K)
    Boiling point 219 °C (426 °F; 492 K)

    Solubility in water

    ~50 g/100 mL (25 °C)
    Acidity (pKa) 8.07 (conjugate acid)
    Pharmacology

    ATC code

    B05BB03 (WHO) B05XX02 (WHO)
    Hazards[1]
    Occupational safety and health (OHS/OSH):

    Main hazards

    Irritant
    GHS labelling:

    Pictograms

    GHS07: Exclamation mark

    Signal word

    Warning

    Hazard statements

    H315, H319, H335

    Precautionary statements

    P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P332+P313, P362, P403+P233, P405
    NFPA 704 (fire diamond)
    NFPA 704 four-colored diamondHealth 2: Intense or continued but not chronic exposure could cause temporary incapacitation or possible residual injury. E.g. chloroformFlammability (red): no hazard codeInstability (yellow): no hazard codeSpecial hazards (white): no code
    2
    Flash point Non-flammable
    Safety data sheet (SDS) External MSDS

    Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

    ☒N verify (what is checkY☒N ?)

    Infobox references

    Buffering features

    edit

    The conjugate acid of tris has a pKa of 8.07 at 25 °C, which implies that the buffer has an effective pH range between 7.1 and 9.1 (pKa ± 1) at room temperature.

    Buffer details

    edit

    Buffer inhibition

    edit

    Preparation

    edit

    Tris is prepared industrially by the exhaustive condensation of nitromethane with formaldehyde under basic conditions (i.e. repeated Henry reactions) to produce the intermediate (HOCH2)3CNO2, which is subsequently hydrogenated to give the final product.[11]

    Uses

    edit

    The useful buffer range for tris (pH 7–9) coincides with the physiological pH typical of most living organisms. This, and its low cost, make tris one of the most common buffers in the biology/biochemistry laboratory. Tris is also used as a primary standard to standardize acid solutions for chemical analysis.

    Tris is used to increase permeability of cell membranes.[12] It is a component of the Moderna COVID-19 vaccine[13] and the Pfizer-BioNTech COVID-19 vaccine for use in children 5 through 11 years of age.[14]

    Medical

    edit

    Tris (usually known as THAM in this context) is used as alternative to sodium bicarbonate in the treatment of metabolic acidosis.[15][16]

    See also

    edit

    References

    edit
    1. ^ "Tromethamine". pubchem.ncbi.nlm.nih.gov.
  • ^ Gomori, G., Preparation of Buffers for Use in Enzyme Studies. Methods Enzymology., 1, 138-146 (1955).
  • ^ a b FISCHER, Beda E.; HARING, Ulrich K.; TRIBOLET, Roger; SIGEL, Helmut (1979). "Metal Ion/Buffer Interactions. Stability of Binary and Ternary Complexes Containing 2-Amino-2(hydroxymethyl)-1,3-propanediol (Tris) and Adenosine 5'-Triphosphate (ATP)". European Journal of Biochemistry. 94 (2). Wiley: 523–530. doi:10.1111/j.1432-1033.1979.tb12921.x. ISSN 0014-2956. PMID 428398.
  • ^ Stanley, David; Tunnicliffe, William (June 2008). "Management of life-threatening asthma in adults". Continuing Education in Anaesthesia, Critical Care & Pain. 8 (3): 95–99. doi:10.1093/bjaceaccp/mkn012. Retrieved 21 July 2017.
  • ^ Hoste, Eric A.; Colpaert, Kirsten; Vanholder, Raymond C.; Lameire, Norbert H.; De Waele, Jan J.; Blot, Stijn I.; Colardyn, Francis A. (May 2005). "Sodium bicarbonate versus THAM in ICU patients with mild metabolic acidosis". Journal of Nephrology. 18 (3): 303–307. ISSN 1121-8428. PMID 16013019.
  • ^ BNF 73 March-September 2017. British Medical Association,, Royal Pharmaceutical Society of Great Britain. London. 21 March 2017. ISBN 978-0857112767. OCLC 988086079.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: others (link)
  • ^ Holert, Johannes; Borker, Aron; Nübel, Laura Lucia; Daniel, Rolf; Poehlein, Anja; Philipp, Bodo (8 January 2024). "Bacteria use a catabolic patchwork pathway of apparently recent origin for degradation of the synthetic buffer compound TRIS". The ISME Journal. 18 (1): wrad023. doi:10.1093/ismejo/wrad023. ISSN 1751-7362.
  • ^ a b "Sigma tris(hydroxymethyl)aminomethane; Tris Technical Bulletin No. 106B" (PDF). Sigma-Aldrich. Retrieved 4 June 2020.
  • ^ Desmarais, WT; et al. (2002). "The 1.20 Å resolution crystal structure of the aminopeptidase from Aeromonas proteolytica complexed with tris: A tale of buffer inhibition". Structure. 10 (8): 1063–1072. doi:10.1016/S0969-2126(02)00810-9. PMID 12176384.
  • ^ Ghalanbor, Z; et al. (2008). "Binding of tris to Bacillus licheniformis alpha-amylase can affect its starch hydrolysis activity". Protein Pept. Lett. 15 (2): 212–214. doi:10.2174/092986608783489616. PMID 18289113.
  • ^ Markofsky, Sheldon, B. (15 October 2011). "Nitro Compounds, Aliphatic". Ullmann's Encyclopedia of Industrial Chemistry. Vol. 24. p. 296. doi:10.1002/14356007.a17_401.pub2. ISBN 978-3527306732.{{cite book}}: CS1 maint: multiple names: authors list (link)
  • ^ Irvin, R.T.; MacAlister, T.J.; Costerton, J.W. (1981). "Tris(hydroxymethyl)aminomethane Buffer Modification of Escherichia coli Outer Membrane Permeability". J. Bacteriol. 145 (3): 1397–1403. doi:10.1128/JB.145.3.1397-1403.1981. PMC 217144. PMID 7009585.
  • ^ Factsheet modernatx.com
  • ^ Vaccines and Related Biological Products Advisory Committee Meeting October 26, 2021 fda.gov
  • ^ Kallet, RH; Jasmer RM; Luce JM; et al. (2000). "The treatment of acidosis in acute lung injury with tris-hydroxymethyl aminomethane (THAM)". American Journal of Respiratory and Critical Care Medicine. 161 (4): 1149–1153. doi:10.1164/ajrccm.161.4.9906031. PMID 10764304.
  • ^ Hoste, EA; Colpaert, K; Vanholder, RC; Lameire, NH; De Waele, JJ; Blot, SI; Colardyn, FA (2005). "Sodium bicarbonate versus THAM in ICU patients with mild metabolic acidosis". Journal of Nephrology. 18 (3): 303–7. PMID 16013019.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Tris&oldid=1222916135"
     



    Last edited on 8 May 2024, at 18:44  





    Languages

     


    العربية
    Català
    Čeština
    Deutsch
    Español
    فارسی
    Français

    Հայերեն
    Italiano
    Nederlands

    Português
    Română
    Русский
    Slovenčina
    Српски / srpski
    Srpskohrvatski / српскохрватски
    Suomi
    Українська

     

    Wikipedia


    This page was last edited on 8 May 2024, at 18:44 (UTC).

    Content is available under CC BY-SA 4.0 unless otherwise noted.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Terms of Use

    Desktop